Hyland's Consumer Health Inc.

Form 483 issued November 29, 2022 · Los Angeles, California

Observations
5
Pages
5
FEI number
2010939

In short: On November 29, 2022, FDA issued a Form 483 with 5 observations to Hyland's Consumer Health Inc. in Los Angeles, California (FEI 2010939). The investigator was Santiago Gallardo Johnson. Most observations concern quality system and production.

At a glance

Quality system and production account for 4 of 5 observations.

Quality system2
Production2
Laboratory controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Written records of investigations into the failure of a batch or any of its components to…

  2. 02

    Control procedures are not established which validate the performance of those manufacturing processes that may be…

  3. 03

    Procedures describing the handling of written and oral complaints related to drug products are…

  4. 04

    EMPLOYEE{S) SIGNATURE The master production and control records are deficient in that they do not include…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Hyland's Consumer Health Inc.?

FDA listed 5 observations on this Form 483, mostly about quality system, production and laboratory controls. The opening words of each observation are shown on this page.

Who inspected Hyland's Consumer Health Inc.?

Santiago Gallardo Johnson is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Hyland's Consumer Health Inc. inspected by FDA?

This Form 483 is dated November 29, 2022.

How do I get the full Form 483 for Hyland's Consumer Health Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free